Thalidomide to Treat Oral Lesions in HIV-Infected Patients

NCT00001524 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

110

Enrollment

NIH

Sponsor class

Conditions

Acquired Immunodeficiency Syndrome
Burning Mouth Syndrome
HIV Infection

Interventions

DRUG: Thalidomide

Sponsor

National Institute of Dental and Craniofacial Research (NIDCR)